REGISTRATION RATES UPDATED AS OF JUNE 13, 2024
KEYNOTE SPEAKERS
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/gray_100.jpg)
Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/levantis_100.jpg)
Henry C. Levantis, JD
United States Attorney, US Attorney’s Office, Middle District of Tennessee, US Department of Justice, Nashville, TN
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/levy_100.jpg)
Joshua S. Levy, JD
Acting United States Attorney; Former Assistant United States Attorney, District of Massachusetts, US Department of Justice, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/romero_100.jpg)
Jacqueline C. Romero, JD
United States Attorney, US Attorney’s Office, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/barzilay_100.jpg)
Regina Barzilay, PhD
School of Engineering Distinguished Professor for AI and Health, MIT Center for Machine Learning in Health; AI Faculty Lead, Jameel Clinic, MIT Computer Science & Artificial Intelligence Lab; Recipient, MacArthur Genius Fellowship, NSF Career Award, and AAAI Squirrel AI Award for Artificial Intelligence for the Benefit of Humanity, Cambridge, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/dentzer_100.jpg)
Susan Dentzer
President and Chief Executive Officer, America’s Physician Groups; Wrote and Hosted PBS documentary, Reinventing American Healthcare; Former Editor in Chief, Health Affairs; Former Health Correspondent, PBS NewsHour, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/potter_100.jpg)
Myrtle Potter
Board, Liberty Mutual, Guardant Health, Opentrons & Univ of Chicago; Former President and CEO, Sumitomo Pharma America & Chair, Sumitomo Pharma UK; Former CEO, Sumitovant Biopharma; Former Vant Operating Chair, Roivant; Former President, Commercial Operations, Genentech; Former President, Cardiovascular/Metabolics, BMS, Cambridge, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/saunders_100.jpg)
Brent Saunders, MBA, JD
Chairman & Chief Executive Officer, Bausch + Lomb; Former Chair, President & CEO, Allergan; President & CEO, Actavis plc; President & CEO, Forest Laboratories; President, Global Consumer Healthcare; Schering-Plough; Co-founder, International Association of Privacy Professionals (IAPP) and Pharmaceutical Compliance Forum (PCF), Miami Beach, FL
ANNUAL UPDATES FROM ADVAMeD, PhRMA AND BIO
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/delacourt_100.jpg)
John Delacourt, JD
Deputy General Counsel, Biotechnology Innovation Organization; Former Chief Antitrust Counsel, Office of Policy Planning, Federal Trade Commission, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/nassar_100.jpg)
Ida Nassar, JD
Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, Drug Enforcement Administration, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/wagner_100.jpg)
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC
FEATURED FACULTY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/amendola_100.jpg)
David Amendola
Director, Resolution Economics; Former, Global Compliance Risk Evaluation and Management, ConvaTec, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/badlan_100.jpg)
Samantha Barrett Badlan, JD
Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/bahl_100.jpg)
Yogesh Bahl, MBA
Partner & Leader, Life Sciences & Healthcare Practice, Resolution Economics; CFO & Head Investor Relations, IACTA Pharma, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/baim_100.jpg)
Eric M. Baim
Partner Dovetail; Former VP, Head of Compliance, US, Shire; Former Executive Director, Global Integrity & Compliance, Novartis, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/bohnenkamp_100.jpg)
Brian A. Bohnenkamp, MHA, JD
Partner, FDA & Life Sciences Practice, King & Spalding, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/bolesh_100.jpg)
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Durham, NC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/bonistalli_100.jpg)
Ryan Bonistalli, JD
Senior Director, Compliance, Ultragenyx; Former Director, Corporate Compliance, Kaleo, San Francisco, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/bragg_100.jpg)
Jennifer Bragg, JD
Partner, Latham & Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/brunetti_100.jpg)
Alfred R. Brunetti, JD
Principal, Porzio, Bromberg & Newman; Former Assistant Prosecutor, Union County Prosecutor’s Office, Morristown, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/chanda_100.jpg)
Parth Chanda, MPA, JD
Founder & CEO, Lextegrity; Former Chief Compliance Counsel – Global Oncology, Pfizer, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/clark_100.jpg)
Andrew Clark, MBA
Partner/Principal, Forensic & Integrity Services, EY, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/cobourn_100.jpg)
Chris Cobourn, MS
Managing Director GP Practice Lead, Helio, Placida, FL
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/cone_100.jpg)
Patricia Cone, PhD
Director, Compliance (R&D, Medical Affairs), Boehringer Ingelheim; Former Head, Global R&D Compliance, Takeda, Ridgefield, CN
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/davella_100.jpg)
BJ D’Avella, MBA
Group Leader, Life Sciences Consulting Group, Paul Hastings, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/datta_100.jpg)
Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/davar_100.jpg)
Mahnu V. Davar, MA, JD
Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/davies_100.jpg)
Adriana Davies, JSM
VP, Compliance & Data Privacy, Smith & Nephew; Former Senior Compliance Director MITG, Medtronic, Jacksonville, FL
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/dawson_100.jpg)
James M. Dawson
VP, Compliance Solutions, Qordata; Former VP & CCO, United Therapeutics; Former VP, Global Compliance Officer, Consumer Healthcare, GSK, Carrboro, NC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/demske_100.jpg)
Gregory Demske, JD
Partner, Goodwin Procter; Former Chief Counsel, HHS Office of Inspector General, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/difrancesca_100.jpg)
Sarah diFrancesca, JD
Executive Director Compliance, Dermatology, Incyte, Chadds Ford, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/doebler_100.jpg)
Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, LLP, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/dunn_100.jpg)
Avia M. Dunn, JD, MBA
Partner, Life Sciences and Health Care, Skadden, Arps, Slate, Meagher & Flom, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/ebel_100.jpg)
Kip Ebel, MBA
Principal, Fraud Investigation & Dispute Services, EY, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/ipc/faculty/elberg_100.jpg)
Jacob T. Elberg, JD
Associate Professor & Director, Center for Pharma Law, Seton Hall School of Law; Former AUSA, US Attorney’s Office, District of New Jersey, Newark, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/falcione_100.jpg)
Andrea Falcione, JD, CCEP
Chief Ethics & Compliance Officer & Head of Advisory Services, Rethink Compliance, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/falcone_100.jpg)
David Falcone, MS
Vice President Global Compliance, Merz Aesthetics; Former Director of Privacy, Ethics and University Compliance Officer, Duke University, Raleigh, NC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/feltz_100.jpg)
Margaret K. Feltz, MA, JD
Vice President, Ethics & Compliance, CCO, Purdue Pharma LP; Former Co-chair, PCF, Stamford, CN
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/fisher_100.jpg)
David Fisher, MS
President & Chief Operating Officer, TD International, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/florence_100.jpg)
Maya P. Florence, JD
Partner, Life Sciences and Health Care, Skadden, Arps, Slate, Meager & Flom, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/franklin_100.jpg)
Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling, LLP; Former Attorney, US Federal Trade Commission, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/garcia_n_100.jpg)
Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda; Former Compliance Head, Rare Disease & Rare Blood Disorders, Sanofi, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/giampetruzzi_100.jpg)
Gary F. Giampetruzzi, JD
Partner & Global Chair Life Sciences Department, Paul Hastings; Former VP, Assistant General Counsel, Pfizer, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/gobena_100.jpg)
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/gordon_100.jpg)
Christine Gordon, JD
CCO & Head of GRC; Governance, Risk & Compliance Function, Olympus; Former Assistant DA, Philadelphia DA’s Office, Bethlehem, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/guerrero_100.jpg)
Jaime Guerrero, JD
Vice President, Global Compliance, Edwards Lifesciences; Former AUSA, United States Attorneys’ Office, Central District of California, Irvine, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/gupta_100.jpg)
Neeraj Gupta, MBA
President & Chief Technology Officer, Cresen Solutions, Chester Springs, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/hall_k_100.jpg)
Kris Hall, JD, CIPP/CIPM
Managing Director, Dovetail Consulting Group; Former VP, Chief Privacy Officer, Celgene, Bridgton, ME
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/harrold_100.jpg)
Kassie Harrold, JD
Executive Vice President, Chief Compliance Officer, Integrity & Compliance, Mallinckrodt; Former Global Compliance Counsel, Solutia, Hampton, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/hayes_100.jpg)
Becky Hayes, MPH, CCEP
Senior Compliance Officer, Training & Communications, Cencora; Former Group Compliance Officer, AmerisourceBergen, Fort Mill, SC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/hercz_100.jpg)
Michael G. Hercz, JD
Senior VP & General Counsel, Sentyn; Former Executive Director, Enterprise Risk Management, Amgen, Los Angeles, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/holloway_100.jpg)
Howard Holloway
Global Governance Lead, Global Medical Affairs & Governance, Patient Oriented Programs, Novartis, Zurich, Switzerland
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/horton_100.jpg)
Casey Horton
Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/johnston_100.jpg)
Amanda Johnston, JD, RAC
Managing Attorney, Gardner Law, PLLC; Adjunct Professor of Law, Mitchell Hamline School of Law, St. Paul, MN
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/jones_100.jpg)
Erin Brown Jones, MA, JD
Partner, Latham & Watkins, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/kaschak_100.jpg)
Melissa Kaschak, CPA, CFE, CISA
Compliance Operations, Olympus; Former Information Protection Officer, Penn Mutual, Allentown, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/kassaby_100.jpg)
Rim El Kassaby, LLM
Director US Business Counseling & Support, Organon, Dubai, UAE
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/kelly_100.jpg)
Kiley Smith Kelly, MBA
Partner/Principal, Forensic & Integrity Services, EY, Philadelphia, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/kossak_100.jpg)
Amy D. Kossak, JD
Partner, Ropes & Gray; Former Senior Trial Counsel, US Department of Justice, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/krishnan_100.jpg)
Lakshmi Krishnan
Lead, Monitoring & Risk Assessment, Takeda; Former Lead, Monitoring & Risk Assessment, Invidior, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/krzeminski_100.jpg)
Olivia Krzeminski, JD
Associate Director Compliance, G&M Health
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/lee_angelique_100.jpg)
Angelique Lee, JD
VP, CCO & Ethics Officer, Jazz Pharmaceuticals; Former VP, Global CCO; R&D Legal Lead, Greenwich Biosciences, Orange County, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/lee_peter_100.jpg)
Peter Lee, JD
Vice President Compliance, Mirati Therapeutics; Former CCO, Provention Bio & Heron Therapeutics, San Diego, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/ledva_100.jpg)
Terri L. Ledva, MS
Director, Ethics & Compliance, Aurobindo Pharma LTD; Former Senior Manager Compliance, Iroko Pharmaceuticals LLC, Philadelphia, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/lipnic_100.jpg)
Victoria A. Lipnic, JD
Partner, Head of Human Capital Strategy Group, Resolution Economics; Former Commissioner & Acting Chair, US EEOC, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/list_100.jpg)
Cristina List, CPA, CCEP
Director, Compliance Advisory Services, MedPro Systems; Former Compliance Officer, Carestream, Mount Arlington, NJ
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/liston_100.jpg)
Kirsten Liston
Principal & Founder, Rethink Compliance; Co-author, The Compliance Entrepreneur’s Handbook, Denver, CO
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/mcewan_100.jpg)
Elaina McEwan
Director, Life Sciences Consulting Group, Litigation Department, Paul Hastings, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/mckenna_100.jpg)
Rosemary McKenna, JD
Director, Regulatory Legal, Organon; Former Director, Regulatory Legal, Merck, Philadelphia, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/moss_100.jpg)
Gregory S. Moss, JD
Chief Corporate Strategy & Legal Officer, Evomunne; Former EVP, General Counsel & Corporate Secretary, CCO, Kadmon Holdings, Palo Alta, CA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/murphy_100.jpg)
Patrick Murphy, JD
SVP Global Head Litigation & Investigations, Fresenius Medical Care; Former General Counsel, Litigation, GE Healthcare, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/oconnor_100.jpg)
Daniel O’Connor
SVP, NXLevel Compliance; Former VP, Learning & Development, Morgan Stanley, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/oakley_100.jpg)
Adam Oakley
Senior Director, Potomac River Partners, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/ogrosky_100.jpg)
Kirk Ogrosky, JD
Partner and Co-Chair, Healthcare Government Enforcement, Goodwin Procter LLP; Deputy Chief, Fraud Section, Criminal Division, US DOJ, Washington, DC
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/papandrikos_100.jpg)
Gus Papandrikos, MBA
Global Head of Compliance Assurance, Daiichi Sankyo; Former Senior Head, Compliance Operations, Global Compliance & Risk Management, Shire, New York, NY
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/pape_100.jpg)
Garrett Pape, JD
Senior Manager, Forensic & Integrity Services, EY, Chicago, IL
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/pelot_100.jpg)
Danielle Pelot, JD
Partner, Choate Hall & Stewart, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/perriello_100.jpg)
Kristen Perriello, JD
Principal, Choate, Hall & Stewart, LLP; Former Special Assistant District Attorney, Suffolk County District Attorney’s Office, Boston, MA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/putcha_100.jpg)
Saraswatha Putcha, MA
Associate Director, Global Risk Assessment & Monitoring, Cresen Solutions, Philadelphia, PA
![](https://www.pharmacongress.com/wp-content/themes/pharma2024/faculty/rah_100.jpg)
John S. Rah, JD
Counsel, Potter & Murdock, Potomac, MD